Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection

AIDS

Volumn 14, Issue 4, 2000, Pages 345-355

  Cossarizza, Andrea ^a,g   Stent, Gianna ^d   Mussini, Cristina ^a   Paganelli, Roberto ^b   Borghi, Vanni ^a   Nuzzo, Cira ^a   Pinti, Marcello ^a   Pedrazzi, Jessica ^a   Benatti, Francesca ^a   Esposito, Roberto ^a   Røsok, Bård ^d   Nagata, Shigekazu ^e   Vella, Stefano ^c   Franceschi, Claudio ^f   De Rienzo, Bruno ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g Section of General Pathology   (Italy)

Author keywords

Acute HIV syndrome; Apoptosis; CD95; CD95L; HIV; Mitochondria

Indexed keywords

CD8 ANTIGEN; CHROMIUM 51; DIDANOSINE; FAS ANTIGEN; INDINAVIR; LAMIVUDINE; MEMBRANE ANTIGEN; MESSENGER RNA; NEVIRAPINE; ZIDOVUDINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; T LYMPHOCYTE; VIRUS LOAD;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; HIV INFECTIONS; HUMANS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MITOCHONDRIA; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034030616     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003100-00007     Document Type: Article

References (40)

1. 1. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991, 87:1710-1715.
2. 2. Groux H, Torpier G, Monté D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992, 175:331-340.
3. 3. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons. Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996, 156:3509-3520.
4. 4. Levy J. HIV pathogenesis and long-term survival. AIDS 1993, 7:1401-1410.
5. 5. Franceschi C, Franceschini MG, Boschini A., et al. Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death Differ 1997, 4:815-822.
6. 6. Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS 1991, 5:1-14.
7. 7. Cossarizza A, Ortolani C, Mussini C, et al. Massive activation of immune cells with an intact T cell repertoire in acute HIV syndrome. J Infect Dis 1995, 172:105-112.
8. 8. Cossarizza A, Ortolani C, Mussini C, et al. Lack of selective Vβ deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T cell repertoire during acute HIV syndrome. AIDS 1995, 9:547-554.
9. 9. Cossarizza A, Mussini C, Mongiardo N, et al. Mitochondria alterations and dramatic tendency to apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 1997, 11:19-26.
10. 10. Cossarizza A, Ortolani C, Forti E, et al. Age-related expansion of functionally inefficient cells with markers of NK activity in Down's syndrome. Blood 1991, 77:1263-1270.
11. 11. Smith D, Sieg S, Kaplan D. Technical note: aberrant detection of cell surface Fas ligand with anti-peptide antibodies. J Immunol 1998, 160:4159-4160.
12. 12. Diviacco S, Norio P, Zentilin L, et al. A novel procedure for quantitative polymerase chain reaction with coamplification of competitive templates. Gene 1992, 122:313-320.
13. 13. Gehri R, Hanh S, Rothen M, et al. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996, 10:9-16.
14. 14. Cossarizza A, Baccarani Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993, 197:40-45.
15. 15. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991, 30:4480-4486.
16. 16. Cossarizza, A., and S. Salvioli. Multicolor fluorescence: HL-60 cells. In Microscopy - Image analysis & 3D reconstruction CD-ROM Vol. 1, Edited by Pawley JW, Robinson JP. West Lafayette, IN: Purdue University Cytometry Laboratory; 1998.
17. 17. Poot M, Zhang YZ, Krämer JA, et al. Analysis of mitochondria morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 1996, 44:1363-1372.
18. 18. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 1995, 184:39-51.
19. 19. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med 1996, 2:317-322.
20. 20. Menzo S, Bagnarelli P, Giacca M, et al. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol 1992, 30:1752-1757.
21. 21. Cossarizza A, Ortolani C, Paganelli R, et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Devel 1996, 86:173-195.
22. 22. Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin KM. Activation of the CD95 (APO-1/Fas) system in T cells from Human Immunodeficiency Virus type-1-infected children. Blood 1996, 88:1741-1746.
23. 23. Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM, Malavasi F. Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens 1997, 49: 7-15.
24. 24. Liu Z, Hultin LE, Cumberland WG, et al. Elevated relative fluorescence intensity of CD38 antigen expression on CD8 T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry 1996, 26:1-7.
25. 25. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial function. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992, 267:5317-5323.
26. 26. Ju ST, Panka DJ, Cul H, et al. Fas(CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 1995, 373:444-448.
27. 27. Cossarizza A, Mussini C, Borghi V, et al. Apoptotic features of peripheral blood mononuclear granulocytes and monocytes during primary, acute HIV infection. Exp Cell Res 1999, 247: 304-311.
28. 28. Uehara T, Miyawaki T, Ohta K, et al. Apoptotic cell death of primed CD45R0+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 1992, 80:452-458.
29. 29. Kamihira S, Yamada Y, Hiragata Y, et al. Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases. Intern Med 1997, 36:166-170.
30. 30. Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease. Proc Natl Acad Sci USA 1997, 94:5860-5865.
31. 31. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998, 4:31-36.
32. 32. Schneider P, Holler N, Bodmer JL, et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998, 187:1205-1213.
33. 33. Medema JP, Scaffidi C, Kischkel FC, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997, 16:2794-2804.
34. 34. Bahr G M, Capron A, Dewulf J, et al. Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection. Blood 1997, 90:896-898.
35. 35. Kaplan D, Sieg S. Role of Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J Virol 1998, 72:6279-6282.
36. 36. Noraz N, Gozlan J, Corbeil J, Brunner T, Spector SA. HIV induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand. AIDS 1997, 11:1671-1680.
37. 37. Badley AD, Dockrell D, Simpson M, et al. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997, 185:55-64.
38. 38. de Maria R, Lenti L, Malisan F, et al. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science 1997, 277:1652-1654.
39. 39. Cossarizza A, Kalashnikova G, Grassilli E, et al. Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level. Exp. Cell Res. 1994, 214:323-330.
40. 40. Richter C, Schweizer M, Cossarizza A, Franceschi C. Control of apoptosis by the cellular ATP level. FEBS Lett 1996, 378:107-110.